Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Editas
Podcast
Editas plans to target high cholesterol with gene editing
The company revealed its new lead program as a possible one-time treatment for high cholesterol.
Eric Sagonowsky
Sep 2, 2025 1:46pm
Intellia cuts 27% of staff as it takes ax to pipeline
Jan 10, 2025 4:00am
Fierce 15: Where are they now?
Jul 26, 2024 6:50am
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Sep 29, 2023 9:30am
Peter Marks: Gene editing has met regulatory reality
Jul 31, 2023 3:14pm
Roche taps new CEO—Chutes & Ladders
Jul 22, 2022 9:30am